Strength
125 mg/mL
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003218851
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2026
Active Ingredients
ABATACEPTApproval Type
Biologic (BLA)
FDA Application
BLA125118On Market Since
7/29/2011
Pharmacological Classes
Decreased Cytokine Activity
Recombinant Fusion Proteins
Selective T Cell Costimulation Modulator
Related Drugs
Same classification
No related drugs found.